Results
26,449 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 |  Lizzie FletcherDSelf |  MSFTMICROSOFT CORPPartial sale | SELL | $1,001 – $15K |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Lizzie FletcherDSelf | MSFTMICROSOFT CORP Partial sale | SELL | $1,001 – $15K |
| May 1, 2026 traded Apr 8, 2026 |
| 34 | Schwartz Richard ToddDirector, Chief Executive Officer |  RSIRush Street Interactive, Inc.Open-market sale · 10b5-1 plan | SELL | $1.56M 55.6K sh | May 1, 2026 traded May 1, 2026 |
| 34 | Schwartz Richard ToddDirector, Chief Executive Officer | RSIRush Street Interactive, Inc. Open-market sale · 10b5-1 plan | SELL | $1.56M 55.6K sh | May 1, 2026 traded May 1, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $418K 3,754 sh | May 1, 2026 traded Apr 29, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $883K 7,796 sh | May 1, 2026 traded Apr 29, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $991K 8,834 sh | May 1, 2026 traded Apr 29, 2026 |
| 32 | Cashman SteveChief Business Officer |  BFLYButterfly Network, Inc.Open-market sale | SELL | $724K 147.5K sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Lizzie FletcherDSelf |  AAPLApple Inc.Partial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 939 sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Lizzie FletcherDSelf |  GOOGLAlphabet Inc.Partial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $221K 1,950 sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 2,208 sh | May 1, 2026 traded Apr 29, 2026 |
| 28 | Sloan SheldonChief Medical Officer |  SYRESpyre Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $764K 10.4K sh | May 1, 2026 traded May 1, 2026 |
| 28 | Larabee Brian KeithSVP & GM - EMS |  ROGROGERS CORPOpen-market sale | SELL | $113K 830 sh | May 1, 2026 traded May 1, 2026 |
| 28 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $377K 5,059 sh | May 1, 2026 traded May 1, 2026 |
| 27 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.39M 19.7K sh | May 1, 2026 traded May 1, 2026 |
| 27 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.48M 21.3K sh | May 1, 2026 traded May 1, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $203K 1,840 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $51K 460 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $190K 1,760 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $226K 2,080 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 520 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $111K 8,458 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Young Tobi M.Director |  HALHALLIBURTON COOpen-market sale | SELL | $21K 500 sh | May 1, 2026 traded Apr 30, 2026 |
| 26 | Schwartz Richard ToddDirector, Chief Executive Officer | RSIRush Street Interactive, Inc. Open-market sale · 10b5-1 plan | SELL | $1.33M 47.2K sh | May 1, 2026 traded May 1, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 8,457 sh | May 1, 2026 traded Apr 30, 2026 |
| 25 | Lizzie FletcherDSelf |  JPMJPMORGAN CHASE & COPartial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |
| 25 | Schmidt MarianneEXECUTIVE OFFICER |  EFSIEAGLE FINANCIAL SERVICES INCOpen-market sale | SELL | $15K 388 sh | May 1, 2026 traded Apr 29, 2026 |
| 25 | Lizzie FletcherDSelf |  AMPAMERIPRISE FINANCIAL INCPartial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |
| 25 | Cox John DDirector |  NWWPNEW PEOPLES BANKSHARES INCOpen-market purchase | BUY | $33K 8,570 sh | May 1, 2026 traded Apr 30, 2026 |
| 24 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $932K 12.8K sh | May 1, 2026 traded May 1, 2026 |
| 24 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $628K 8,777 sh | May 1, 2026 traded May 1, 2026 |
| 23 | Stetz MattiasChief Operating Officer | RSIRush Street Interactive, Inc. Open-market sale · 10b5-1 plan | SELL | $562K 20.0K sh | May 1, 2026 traded May 1, 2026 |
| 23 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 440 sh | May 1, 2026 traded Apr 29, 2026 |
| 22 | Palmer Stephen RVice President of Accounting |  CVNACARVANA CO.Open-market sale · 10b5-1 plan | SELL | $395K 1,000 sh | May 1, 2026 traded May 1, 2026 |
| 22 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 400 sh | May 1, 2026 traded May 1, 2026 |
| 20 | Lizzie FletcherDSelf |  PWRQUANTA SERVICES, INC.Partial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |
| 20 | Burrows Scott LChief Financial Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $892K 12.5K sh | May 1, 2026 traded May 1, 2026 |
| 20 | Lizzie FletcherDSelf |  ETNEaton Corp plcPartial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |
| 20 | Lizzie FletcherDSelf |  KLACKLA CORPPartial sale | SELL | $1,001 – $15K | May 1, 2026 traded Apr 8, 2026 |